renal impairment
Showing 26 - 50 of >10,000
Healthy, Renal Impairment Trial in Porto (Cenerimod)
Recruiting
- Healthy
- Renal Impairment
-
Porto, PortugalBlueClinical Phase 1 Hospital de Prelado
Nov 15, 2022
Renal Impairment Trial (Efgartigimod IV)
Not yet recruiting
- Renal Impairment
- Efgartigimod IV
- (no location specified)
Jun 22, 2023
Chronic Kidney Disease Trial in Beijing (Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin)
Recruiting
- Chronic Kidney Disease
- Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin
-
Beijing, ChinaPeking University Third Hospital
Feb 27, 2023
Renal Impairment Trial in Kiel (JNJ-73763989)
Recruiting
- Renal Impairment
-
Kiel, GermanyCRS Clinical Research Services Kiel GmbH
Aug 2, 2022
Chronic Kidney Diseases, Diabetes, PreDiabetes Trial in Vienna (Therapeutic carbohydrate restriction combined with an
Recruiting
- Chronic Kidney Diseases
- +3 more
- Therapeutic carbohydrate restriction combined with an SGLT-2-Inhibitor
-
Vienna, Austria6th Medical Department with Nephrology and Dialysis, Clinik Otta
Oct 16, 2023
Renal Impairment Trial in Beijing (HSK7653 tablets)
Recruiting
- Renal Impairment
- HSK7653 tablets
-
Beijing, ChinaBeijing Jishuitan Hospital
Aug 10, 2022
Renal Impairment Trial (Drug: PF-07923568)
Not yet recruiting
- Renal Impairment
- Drug: PF-07923568
- (no location specified)
Sep 7, 2023
Hyperlipidemia, Mixed Dyslipidemia Trial in Denver (Evolocumab)
Completed
- Hyperlipidemia
- Mixed Dyslipidemia
- Evolocumab
-
Denver, ColoradoResearch Site
Nov 3, 2022
Renal Impairment Trial in New Zealand, United States (AR882 Single Dose, AR882 Multiple Dose)
Completed
- Renal Impairment
- AR882 Single Dose
- AR882 Multiple Dose
-
Orlando, Florida
- +3 more
Aug 3, 2022
ACS - Acute Coronary Syndrome Trial in Miami (MT1002 for Injection)
Terminated
- ACS - Acute Coronary Syndrome
- MT1002 for Injection
-
Miami, FloridaPanax Clinical Research, LLC.
Jan 23, 2023
Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes
Active, not recruiting
- Type 2 Diabetes Mellitus
-
Tokyo, JapanTakeda Selected Site
Oct 28, 2022
Renal Impairment Trial in San Antonio (Saroglitazar magnesium)
Recruiting
- Renal Impairment
- Saroglitazar magnesium
-
San Antonio, TexasAmerican Research Corporation @ Texas Liver Institute
Apr 23, 2022
Renal Impairment Trial in Suzhou (DBPR108 tablets)
Completed
- Renal Impairment
- DBPR108 tablets
-
Suzhou, ChinaFirst Affiliated Hospital of Soochow University
May 6, 2022
Diabetes, Type 2, Renal Impairment, Healthy Trial in Miami, Orlando, Saint Paul (PF-06882961 20 mg)
Completed
- Diabetes Mellitus, Type 2
- +2 more
- PF-06882961 20 mg
-
Miami, Florida
- +2 more
Mar 18, 2022